Mikkael Sekeres, MD on Phase II Study of Pevonedistat + Azacitidine: Is This Combination Tolerable? @MikkaelSekeres #ASCO @ClevelandCinic #ASCO2020

Mikkael Sekeres, MD on Phase II Study of Pevonedistat + Azacitidine: Is This Combination Tolerable? @MikkaelSekeres #ASCO @ClevelandCinic #ASCO2020

User Photo
Cancer-News

3 months
20 Views
Share
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 1
Category:
Description:
Mikkael Sekeres, MD @MikkaelSekeres of Cleveland Clinic @ClevelandClinic discusses the phase II study of pevonedistat + azacitidine vs. A in patients with higher-risk myelodysplastic syndromes/chronic myelomonocytic leukemia, or low-blast acute myelogenous leukemia presented at this year's virtual ASCO.
Up Next Autoplay